nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
|
Hadjiyianni, Irene |
|
2016 |
8 |
1 |
p. 149-166 |
artikel |
2 |
Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study
|
Porath, Avi |
|
2016 |
8 |
1 |
p. 167-176 |
artikel |
3 |
Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes
|
Kreider, Kathryn Evans |
|
2017 |
8 |
1 |
p. 1-7 |
artikel |
4 |
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
|
Anderson, John E. |
|
2016 |
8 |
1 |
p. 33-53 |
artikel |
5 |
Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures
|
Scattolini, Valentina |
|
2016 |
8 |
1 |
p. 207 |
artikel |
6 |
Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom
|
Hunt, Barnaby |
|
2017 |
8 |
1 |
p. 129-147 |
artikel |
7 |
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
|
Li, Feng-fei |
|
2016 |
8 |
1 |
p. 177-187 |
artikel |
8 |
Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study
|
Al Hayek, Ayman A. |
|
2016 |
8 |
1 |
p. 75-83 |
artikel |
9 |
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
|
Haak, Thomas |
|
2016 |
8 |
1 |
p. 55-73 |
artikel |
10 |
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries
|
Divino, Victoria |
|
2017 |
8 |
1 |
p. 115-128 |
artikel |
11 |
How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
|
Muñoz-Garach, Araceli |
|
2016 |
8 |
1 |
p. 9-22 |
artikel |
12 |
Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data
|
Kaku, Kohei |
|
2017 |
8 |
1 |
p. 189-195 |
artikel |
13 |
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes
|
Bebakar, Wan Mohamaed Wan |
|
2016 |
8 |
1 |
p. 197-205 |
artikel |
14 |
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review
|
Black, Cody D. |
|
2016 |
8 |
1 |
p. 23-31 |
artikel |
15 |
Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis
|
Lorenzi, Maria |
|
2016 |
8 |
1 |
p. 85-99 |
artikel |
16 |
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
|
Linjawi, Sultan |
|
2016 |
8 |
1 |
p. 101-114 |
artikel |